We carried out an anti-depression experiment in vivo to identify how TTWC can improve depression-like behavior and alleviate neuronal damage in the hippocampus and prefrontal cortex by regulating the levels of neurotransmitters, the HPA axis, and the NLRP3 signaling pathway. The gene discussed is NLRP3; the disease is depressive symptom measurement.